• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC PROCOL BIOLOGIC VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC PROCOL BIOLOGIC VASCULAR GRAFT Back to Search Results
Model Number HJL016-40-N
Device Problem Material Puncture/Hole (1504)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/29/2021
Event Type  malfunction  
Manufacturer Narrative
We have not received the section of the graft with the defect for investigation since the section was discarded by the user.Hence, we could not confirm the exact nature of the reported malfunction.Procol vacular bioprosthesis is derived from a single length of bovine mesenteric vein that is chemically cross-linked with glutaraldehyde.Natural variations even in the same graft is possible.Collateral branches are ligated with surgical suture and the graft is inspected under pulsatile flow conditions at simulated physiological internal graft pressure.Each graft is pressurized between 2.7-4.0 psi ( 139 - 206 mmhg) during the inspection process.If pressure exceeds 4 psi, the vessel is rejected for 'overpressurized' and discarded.Under a pressurized condition, each graft is inspected by the manufacturing operators for any presence of hole, tear or swelling.An od gage is passed over the entire length of the vessel.If any section of the graft appeared to be swollen or did not pass through the gage smoothly, then that section of the graft is rejected by the technician.Each graft is again inspected by the qc technician for these attributes.A batch record review could not be conducted at this time since the lot number of the affected graft was not provided.We have also reviewed our complaint history for last 3 years.We have not received any other complaints of a similar nature.Hence, we consider this to be an isolated incident.
 
Event Description
The procol graft tore during pre-use check.This section with the defect was cut off and the rest of the graft was implanted.There was no harm to the patient as the result of this malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROCOL BIOLOGIC VASCULAR GRAFT
Type of Device
VASCULAR GRAFT
Manufacturer (Section D)
LEMAITRE VASCULAR, INC
63 second ave
burlington MA 01803
Manufacturer (Section G)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer Contact
pragya thikey
63 second ave
burlington, MA 01803
7812212266
MDR Report Key12321636
MDR Text Key268028872
Report Number1220948-2021-00079
Device Sequence Number1
Product Code LXA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 08/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/13/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberHJL016-40-N
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/14/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Type of Device Usage Initial
Patient Sequence Number1
-
-